Chiralgen, Ltd.
3Patents
3Active
3Granted
45Portfolio score
Filing activity: Sep 15, 2010 → Nov 28, 2011 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8859755B2 | Method for preparing ribonucleoside phosphorothioate | Emerging Cross-Sectional Technologies | 44 | Active |
| US8822671B2 | 2'-O-modified RNA | Emerging Cross-Sectional Technologies | 36 | Active |
| US8470987B2 | Protective group for synthesis of RNA and derivative | Emerging Cross-Sectional Technologies | 36 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.